|
Signed Export Contract for PPC Formulation Lipolysis to Japan
2016.05.24
|
|---|
|
An export contract was signed with Vellesshima Medical, located in Tokyo, for PPC formulation medicine (product name: Ripolysis) at a scale of 3,000 vials per month.
Daehan New Pharm has been regularly exporting 10,000 vials per month of 50ml Vitamin C to Japan since 2011. Although entering the Japanese market is initially challenging, once established, it allows for long-term and stable supply without price constraints. Daehan New Pharm plans to successfully launch Lipolysis, develop additional products, and actively expand into the Japanese market.
Since receiving the $10 million Export Tower award in 2015, the company has been more actively promoting overseas exports. It is strengthening partnerships in strategic overseas bases such as Russia and vigorously expanding into new markets. Well-being products inspired by the Korean Wave have shown good responses in China and Southeast Asia, leading to active overseas market development. |


Home